{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:17:30Z","timestamp":1790338650118,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Research & Special Projects Grant of China","award":["201002020"],"award-info":[{"award-number":["201002020"]}]},{"name":"Health Research & Special Projects Grant of China","award":["201502005"],"award-info":[{"award-number":["201502005"]}]},{"name":"The National Natural Science Fund","award":["81570505"],"award-info":[{"award-number":["81570505"]}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","award":["2015CB943203"],"award-info":[{"award-number":["2015CB943203"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytomegalovirus (CMV) infection can significantly complicate and worsen the condition of acute severe ulcerative colitis (UC) patients. We aimed to explore the predictive risk factors to prevent and identify CMV infection at an early stage in acute UC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 115 moderate-to-severe active UC patients from 17 hospitals throughout China were enrolled. Active CMV infection was diagnosed by one of the following: CMV pp65 antigens, CMV IgM antibodies or CMV DNA. We identified the independent risk factors by multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 64 of 115 active UC patients had active CMV infection. Compared to the non-CMV-infected patients, the CMV-infected patients had a tendency to be male and to exhibit abdominal pain; fever; oral ulcers; eosinopenia; low albumin, immunoglobulin (Ig) A, IgM, and IgG levels; increased high-sensitivity C-reactive protein (hsCRP) levels; hyponatremia; pancolonic lesions; initial onset type; severe activity; and glucocorticoid (high-dose) and immunosuppressive agent use (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). In further multivariate analyses, the use of high-dose glucocorticoids (OR 13.55, 95% CI 2.49\u201373.61,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and immunosuppressive agents (OR 11.23, 95% CI 1.05\u2013119.99,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) were independent risk factors for CMV infection. A decrease eosinophil and albumin levels were risk factors for CMV infection. With every 0.1*10^9\/L decrease in the peripheral blood eosinophil level or 1\u2009g\/L decrease in the serum albumin level, the risk for CMV infection in UC patients increased by 5.21-fold (1\/0.192) or 1.19-fold (1\/0.839), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High-dose glucocorticoid and immunosuppressive agent treatment significantly increase the risk of CMV infection, and correcting eosinopenia and low albumin levels may help prevent CMV infection in UC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01434-5","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T05:02:41Z","timestamp":1599282161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Hong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Owyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naizhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"issue":"9","key":"1434_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.7326\/0003-4819-119-9-199311010-00010","volume":"119","author":"RW Goodgame","year":"1993","unstructured":"Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med. 1993;119(9):924\u201335.","journal-title":"Ann Intern Med"},{"key":"1434_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1743-422X-10-43","volume":"10","author":"F Yi","year":"2013","unstructured":"Yi F, Zhao J, Luckheeram RV, et al. The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virol J. 2013;10:43.","journal-title":"Virol J"},{"issue":"12","key":"1434_CR3","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","volume":"101","author":"A Kandiel","year":"2006","unstructured":"Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101(12):2857\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1434_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10620-010-1126-4","volume":"55","author":"JJ Kim","year":"2010","unstructured":"Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010;55(4):1059\u201365.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1434_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.dld.2005.01.011","volume":"37","author":"G Maconi","year":"2005","unstructured":"Maconi G, Colombo E, Zerbi P, et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis. 2005;37(6):418\u201323.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"1434_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.crohns.2013.12.014","volume":"8","author":"JW Kim","year":"2014","unstructured":"Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014;8(7):693\u2013701.","journal-title":"J Crohns Colitis"},{"issue":"10","key":"1434_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ecco-jcc\/jjw071","volume":"10","author":"E Zag\u00f3rowicz","year":"2016","unstructured":"Zag\u00f3rowicz E, Bugajski M, Wieszczy P, Pietrzak A, Magdziak A, Mr\u00f3z A. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of Cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis. 2016;10(10):1205\u201311.","journal-title":"J Crohns Colitis"},{"issue":"10 Suppl","key":"1434_CR8","first-page":"S59","volume":"46","author":"Y Wada","year":"2003","unstructured":"Wada Y, Matsui T, Matake H, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum. 2003;46(10 Suppl):S59\u201365.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"1434_CR9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/ecco-jcc\/jjx105","volume":"11","author":"M Harbord","year":"2017","unstructured":"Harbord M, Eliakim R, Bettenworth D, et al. Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis. 2017;11(12):1512.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1434_CR10","first-page":"173","volume":"2","author":"Department of inflammatory bowel disease CSoG","year":"2018","unstructured":"Department of inflammatory bowel disease CSoG. Consensus on diagnosis and Management of Inflammatory Bowel Disease. Chin J Dig. 2018;2(3):173\u201390.","journal-title":"Chin J Dig"},{"issue":"4947","key":"1434_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041\u20138.","journal-title":"Br Med J"},{"issue":"5","key":"1434_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","volume":"99","author":"JF Colombel","year":"2004","unstructured":"Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004;99(5):878\u201383.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1434_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/MIB.0000000000001095","volume":"23","author":"H Yang","year":"2017","unstructured":"Yang H, Zhou W, Lv H, et al. The association between CMV Viremia or endoscopic features and Histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflamm Bowel Dis. 2017;23(5):814\u201321.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1434_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5009\/gnl13427","volume":"8","author":"YS Kim","year":"2014","unstructured":"Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver. 2014;8(6):643\u20137.","journal-title":"Gut Liver"},{"issue":"4","key":"1434_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/MIB.0000000000000675","volume":"22","author":"HS Lee","year":"2016","unstructured":"Lee HS, Park SH, Kim SH, et al. Risk factors and clinical outcomes associated with Cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis. 2016;22(4):912\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"1434_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/apt.13124","volume":"41","author":"K Sager","year":"2015","unstructured":"Sager K, Alam S, Bond A, Chinnappan L, Probert CS. Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(8):725\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1434_CR17","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41385-018-0041-4","volume":"11","author":"EA Dennis","year":"2018","unstructured":"Dennis EA, Smythies LE, Grabski R, et al. Cytomegalovirus promotes intestinal macrophage-mediated mucosal inflammation through induction of Smad7. Mucosal Immunol. 2018;11(6):1694\u2013704.","journal-title":"Mucosal Immunol"},{"issue":"3","key":"1434_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00054725-200405000-00011","volume":"10","author":"DW Hommes","year":"2004","unstructured":"Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis. 2004;10(3):245\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1434_CR19","first-page":"949","volume":"3","author":"AJ Cusano","year":"1990","unstructured":"Cusano AJ, Thies HL, Siegal FP, Dreisbach AW, Maesaka JK. Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1990;3(10):949\u201353.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1434_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.intimp.2004.09.006","volume":"5","author":"E Sarmiento","year":"2005","unstructured":"Sarmiento E, Fern\u00e0ndez-Y\u00e1\u00f1ez J, Mu\u00f1oz P, et al. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol. 2005;5(1):97\u2013101.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"1434_CR21","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1016\/j.transproceed.2005.09.153","volume":"37","author":"E Sarmiento","year":"2005","unstructured":"Sarmiento E, Rodr\u00edguez-Molina J, Mu\u00f1oz P, et al. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Transplant Proc. 2005;37(9):4046\u20139.","journal-title":"Transplant Proc"},{"issue":"1","key":"1434_CR22","first-page":"59","volume":"19","author":"LFF Zhou","year":"2003","unstructured":"Zhou LFF, Jiang J, et al. Changes of immunity function in cytomegalovirus infection. Immunol J. 2003;19(1):59\u201364.","journal-title":"Immunol J"},{"issue":"2","key":"1434_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/gastro\/gou082","volume":"3","author":"T Rai","year":"2015","unstructured":"Rai T, Wu X, Shen B. Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease. Gastroenterol Rep (Oxf). 2015;3(2):115\u201321.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"1434_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00442219","volume":"147","author":"T Klemola","year":"1988","unstructured":"Klemola T, Savilahti E, Koskimies S. Transient IgA and IgM deficiencies are frequent in children with ulcerative colitis. Eur J Pediatr. 1988;147(2):184\u20137.","journal-title":"Eur J Pediatr"},{"issue":"10","key":"1434_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ibd.20498","volume":"14","author":"E Dom\u00e8nech","year":"2008","unstructured":"Dom\u00e8nech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008;14(10):1373\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1434_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00000478-200403000-00009","volume":"28","author":"N Kambham","year":"2004","unstructured":"Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004;28(3):365\u201373.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1434_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MCG.0000000000000758","volume":"51","author":"T Shukla","year":"2017","unstructured":"Shukla T, Singh S, Tandon P, McCurdy JD. Corticosteroids and Thiopurines, but not tumor necrosis factor antagonists, are associated with Cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51(5):394\u2013401.","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"1434_CR28","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/MIB.0000000000000412","volume":"21","author":"S Pillet","year":"2015","unstructured":"Pillet S, Jarlot C, Courault M, et al. Infliximab does not worsen outcomes during flare-ups associated with Cytomegalovirus infection in patients with ulcerative colitis. Inflamm Bowel Dis. 2015;21(7):1580\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1434_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MOG.0b013e32835ab29a","volume":"29","author":"SP Hogan","year":"2013","unstructured":"Hogan SP, Waddell A, Fulkerson PC. Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol. 2013;29(1):7\u201314.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"1434_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI108166","volume":"56","author":"DA Bass","year":"1975","unstructured":"Bass DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest. 1975;56(4):870\u20139.","journal-title":"J Clin Invest"},{"issue":"4","key":"1434_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jcrc.2010.03.002","volume":"25","author":"H Shaaban","year":"2010","unstructured":"Shaaban H, Daniel S, Sison R, Slim J, Perez G. Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care. 2010;25(4):570\u20135.","journal-title":"J Crit Care"},{"issue":"2","key":"1434_CR32","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/cc6883","volume":"12","author":"K Abidi","year":"2008","unstructured":"Abidi K, Khoudri I, Belayachi J, et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care. 2008;12(2):R59.","journal-title":"Crit Care"},{"issue":"3","key":"1434_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000479865","volume":"96","author":"A Levin","year":"2017","unstructured":"Levin A, Yaari S, Stoff R, Caplan O, Wolf DG, Israeli E. Diagnosis of Cytomegalovirus infection during exacerbation of ulcerative colitis. Digestion. 2017;96(3):142\u20138.","journal-title":"Digestion"},{"issue":"7","key":"1434_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","volume":"11","author":"M Harbord","year":"2017","unstructured":"Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and Management of Ulcerative Colitis. Part 2: current management. J Crohns Colitis. 2017;11(7):769\u201384.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01434-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T19:09:29Z","timestamp":1630782569000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01434-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01434-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20360\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"12 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All aspects of this study were approved by the Peking Union Medical College Hospital & Chinese Academy Medical Science Ethics Committee (IRB number: S-703).All patients participating gave written informed consent and authorization for use of data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}